All posts by administrator

Top Read: Ventriculocisternostomy versus ventriculoperitoneal shunt in the treatment of hydrocephalus: A retrospective, long-term observational study.

Clin Neurol Neurosurg. 2014 Jul;122:92-6. doi: 10.1016/j.clineuro.2014.03.022. Epub 2014 Mar 26.

Ventriculocisternostomy versus ventriculoperitoneal shunt in the treatment of hydrocephalus: A retrospective, long-term observational study.

Abstract

OBJECTIVE:

The goal of this study was the retrospective analysis of long-term data on endoscopic ventriculocisternostomy versus ventriculoperitoneal shunt placement in the treatment of hydrocephalus.

METHODS:

A total of 159 patients were included in the study. One hundred and twenty-three patients received a ventriculoperitoneal shunt, whereas 36 patients were treated with an endoscopic procedure. Only patients with a postoperative observation period of at least 3 years were included in the analyses of the long-term data. In addition to general patient and operation data, the number and frequency of perioperative complications (infections, dysfunctions) and the frequency and type of necessary revision operations were collected.

RESULTS:

The average observation period was 69 months for both groups. The risk of operative revision was significantly elevated in the shunt group despite a comparable observation period. Whereas 86.11% of the endoscopy group did not require an operative revision, that only applied to 68.85% of the shunt group. The complication rate was 42.7% in the shunt group per procedure, which was clearly higher than in the endoscopy group at only 9.4%.

CONCLUSION:

The risk of operative revision and/or complications is significantly lower in the endoscopic ventriculocisternostomy group compared to the ventriculoperitoneal shunt group. Given the appropriate indication, endoscopic ventriculocisternostomy is thus the treatment of choice.

Mensaje del Presidente de la Sociedad Española de Neurocirugía

Atravesamos tiempos difíciles por las recesiones económicas y el progresivo deterioro de la figura del médico, que se va minimizando frente a instituciones y órganos políticos que se valen de nuestros méritos y complejo trabajo, para encumbrarse a ellos mismos y conseguir resultados económicos o políticos sin contar con la opinión de los protagonistas de la película que somos nosotros y no ellos.

Como primeros objetivos nos marcamos la adaptación del decreto de troncalidad, si termina aprobándose, a nuestra especialidad y la mejora de la formación del residente que va unido a la disminución del número de plazas convocadas y del paro laboral que se nos avecina.

Otro objetico importante es la la creación de una figura a designar entre los miembros para “relaciones internacionales”, con reconocido prestigio, mente clara y suficientes contactos internacionales, especialmente en Sudamérica, para dar salida al paro laboral que ya está llamando a la puerta.

Carlos Ruiz-Ocaña Montalvo

SENEC 2015

Organizado por el Servicio de Neurocirugía del Hospital de Navarra

Capturasenec2015

El tema principal será “La atención multidisciplinar al paciente: la Neurocirugía y su relación con las Neurociencias”

L.C ALENCASTRO Neurocirujano, BRASIL
A. ARIZA Neuropatólogo, ESPAÑA
MITCHEL BERGER Neurocirujano, EE.UU
E. CÁCERES Traumatólogo, ESPAÑA
A. CASASCO Neurovascular intervencionista, ESPAÑA
V. DELETIS Neurofisiólogo, CROACIA
H. DUFFAU Neurocirujano, FRANCIA
M.T LAWTON Neurocirujano, EE.UU
A. PERRY Neuropatólogo, EE.UU
D. ROSENTHAL Neurocirujano, ALEMANIA
F. SALA Neurocirujano, ITALIA
A. TRAMPUZ Enfermedades infecciosas, ALEMANIA

Resumen del 19 Congreso Nacional de la Sociedad Española de Neurocirugía

El lema fué: ”Controversias en la Neurocirugía actual”
Los asuntos sobre los que se presentó las controversias fueron: base de cráneo, docencia y publicaciones, funcional, hidrocefalias, nervio periférico, neuroanatomía quirúrgica, neurociencias, neurooncología, neurotrauma, pediatría, radiocirugía, raquis y vascular.

En el tema de vascular se abordó el tratamiento de los aneurismas cerebrales no rotos, en los que unos profesionales optan por operarlos y otros por embolizarlos.

La Beca para Residentes 2014 fue otorgada al Dr. Josue Moisés Avecillas Chasin del Hospital Clínico de San Carlos de Madrid.

La medalla de oro de la SENEC ha sido asignada al Dr. D. Frederic Bartumeus Jené.

CONSULTA DE LAS PLAZAS ADJUDICADAS PARA LA REALIZACIÓN DE LA ESPECIALIDAD EN ESPAÑA

Consulta de las plazas adjudicadas PDF

Si bien se han reducido casi al 50% respecto al 2012, demuestran que el nivel de compromiso, coherencia interna y credibilidad no es adecuado.

El número total de plazas disminuye a 26, pero está muy lejos del cero que se planteó como objetivo.

La responsabilidad no es del Ministerio, ni de la SENEC o Comisión Nacional, es del responsable de la Unidad Docente, Comisión de Docencia o Gerente del Hospital que solicita plaza MIR, que desconoce u olvida que hay que renunciar a dicha plaza.

La previsión del centenar de neurocirujanos en paro que se espera en los próximos años pone en evidencia la capacidad de autogestión.

¿Qué credibilidad tenemos frente a la sociedad en general si sabedores de esta calamidad, la alentamos con 26 nuevas plazas?.

Evidentemente la autorregulación desde los Servicios ha fracasado.

Fuente: Sociedad Española de Neurocirugía

Clinical Fellowship – Head and Neck Oncology/Skull Base Surgery

Aurora-St. Lukes’s Hospital Fellowship in Head and Neck Oncologic Surgery and Skull Base Surgery is a one year fellowship intended for Otolaryngologists-Head and Neck Surgeons who are Board Eligible (American Board of Otolaryngology) or a Fellow of the Royal College of Surgeons of Canada.

During the one year fellowship, Fellows will gain experience in both Head and Neck Oncologic Surgery and Skull Base Surgery.   The Head and Neck Oncology component will be supervised by Dr. Martin Corsten, and will consist of clinical and operative exposure to mucosal Head and Neck Cancer, salivary gland malignancies, head and neck melanoma, and thyroid pathology.   The Skull Base Surgery component will be supervised by Dr. Martin Corsten and Dr. Amin Kassam, and will consist of exposure to both Endoscopic Endonasal Approaches to the skull base as well as conventional open skull base approaches.   The Fellow will have an opportunity to learn the intricacies of skull base anatomy from both the dorsal and ventral perspectives.  The 360o Cranial Base Laboratory is equipped with state-of the-art microscopic and endoscopic cadaveric dissection stations that are augmented with powerful imaging and navigation platforms.  Fellows will master both conventional and endoscopic endonasal skull base approaches by observing them in the operating rooms and then performing them on cadaveric specimens in the laboratory.  Subsequently, Fellows will be immersed in the high-volume clinical Head and Neck Oncology and Skull Base service where they will function as junior staff members.

The fellowship program is academically oriented. Research projects with focus on Head and Neck Oncology and Skull Base Surgery are encouraged and supported. Fellows are expected to submit at least two manuscripts for publication annually. Fellows are also encouraged to submit abstracts for major national and international meetings.

Unique Features

1) Exposure to full range of Head and Neck Oncology.

2) Comprehensive approach to minimally invasive skull base surgery: the goal is not to promote one approach over the other; instead, the Fellow will gain excellent experience in both conventional and endoscopic approaches.

3) Easy and encouraged access to the 360 Cranial Base Laboratory

4) The spirit of collegiality nurtured by our team. We “listen” to and “learn” from our fellows as much (if not more) than they “listen” and ” learn” from us.

5) Innovation is welcomed and encouraged by each of our team members.

Fellowship Objectives

Objectives of Fellowship

•                     To gain sufficient clinical experience in Head and Neck Oncology, including exposure to multi-disciplinary clinical conferences on Head and Neck Cancer lesions.

•                     To gain sufficient clinical experience in complex Skull Base surgery; both conventional and endoscopic.

•         To actively participate in Head and Neck Oncology and Skull Base research.

•         To have the opportunity to publish and establish expertise in the areas above, to prepare for an academic career and consultative service in this subspecialty.

Eligibility and Qualifications

The candidate should be a Board Eligible Otolaryngologist – Head and Neck Surgeon  (American Board of Otolaryngology) or a Fellow of the Royal College of Surgeons of Canada) who is eligible for a Wisconsin medical license. Non US citizens must be eligible for an H1-B visa.

Stipends and Benefits

The ANI offers a highly competitive compensation package. Details will be discussed during the interview.

Selection Process

Eligible applicants should direct their CVs and letter of intent to the fellowship program director. The letter of intent should specify the desired start date. Competitive  applicants will be invited for an interview. Applicants are evaluated on the basis of their academic standing, research productivity, letters of references, future goals and objectives.

For more information visit us at:

Www.aurora.org/ANII or

http://www.aurorahealthcare.org/services/neurology-neurosurgery/neuroscience-innovation-institute